Thank you very much for the question.
We are doing the consulting now. We are in the phase of putting out the proposals and getting the feedback.
One thing we have done is to put out information to potential licensed producers. We are in dialogue with them, asking them to think about what the seed strains might be. A variety of strains might then be available, for example, and some people might find more pain relief from certain strains than others.
Again, in a more highly regulated, regularized environment, we would be able to have several strains that licensed producers would develop. At this stage, that's still in development, as we are in the transition mode.